These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1786 related articles for article (PubMed ID: 17625587)

  • 1. The resurgence of platinum-based cancer chemotherapy.
    Kelland L
    Nat Rev Cancer; 2007 Aug; 7(8):573-84. PubMed ID: 17625587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent updates in the clinical use of platinum compounds for the treatment of gynecologic cancers.
    Muggia FM
    Semin Oncol; 2004 Dec; 31(6 Suppl 14):17-24. PubMed ID: 15726530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current status and future prospects for satraplatin, an oral platinum analogue.
    Choy H; Park C; Yao M
    Clin Cancer Res; 2008 Mar; 14(6):1633-8. PubMed ID: 18347164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of resistance of human tumours to anticancer drugs of the platinum family: a review.
    Ferguson PJ
    J Otolaryngol; 1995 Aug; 24(4):242-52. PubMed ID: 8551538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New-generation platinum agents for solid tumors.
    Shah N; Dizon DS
    Future Oncol; 2009 Feb; 5(1):33-42. PubMed ID: 19243296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolution of chemotherapy with platinum compounds.
    Walker EM; Walker SM
    Ann Clin Lab Sci; 1999; 29(4):263-74. PubMed ID: 10528825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platinum-based anticancer agents: innovative design strategies and biological perspectives.
    Ho YP; Au-Yeung SC; To KK
    Med Res Rev; 2003 Sep; 23(5):633-55. PubMed ID: 12789689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preclinical perspectives on the use of platinum compounds in cancer chemotherapy.
    Farrell NP
    Semin Oncol; 2004 Dec; 31(6 Suppl 14):1-9. PubMed ID: 15726528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanocapsules of platinum anticancer drugs: development towards therapeutic use.
    Bryde S; de Kroon AI
    Future Med Chem; 2009 Nov; 1(8):1467-80. PubMed ID: 21426060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The status of platinum anticancer drugs in the clinic and in clinical trials.
    Wheate NJ; Walker S; Craig GE; Oun R
    Dalton Trans; 2010 Sep; 39(35):8113-27. PubMed ID: 20593091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Satraplatin: an orally available platinum analog for the treatment of cancer.
    Choy H
    Expert Rev Anticancer Ther; 2006 Jul; 6(7):973-82. PubMed ID: 16831070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of the platinum analogues in bladder cancer cell lines.
    Powles T; Perry J; Shamash J; Liu W; Oliver T; Joel S
    Urol Int; 2007; 79(1):67-72. PubMed ID: 17627172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Broadening the clinical use of platinum drug-based chemotherapy with new analogues. Satraplatin and picoplatin.
    Kelland L
    Expert Opin Investig Drugs; 2007 Jul; 16(7):1009-21. PubMed ID: 17594186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular mechanisms of platinum resistance: still searching for the Achilles' heel.
    Wernyj RP; Morin PJ
    Drug Resist Updat; 2004; 7(4-5):227-32. PubMed ID: 15533760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Excision repair cross-complementation group 1 (ERCC1) in platinum-based treatment of non-small cell lung cancer with special emphasis on carboplatin: a review of current literature.
    Vilmar A; Sørensen JB
    Lung Cancer; 2009 May; 64(2):131-9. PubMed ID: 18804893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Anticancer drugs used in medicine and being in clinical research].
    Malinowska K; Modranka R; Kedziora J
    Pol Merkur Lekarski; 2007 Sep; 23(135):165-9. PubMed ID: 18080687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meeting report on 8th International Symposium on Platinum and Other Metal Coordination Compounds in Cancer Chemotherapy.
    Kelland LR
    J Inorg Biochem; 1999 Oct; 77(1-2):121-4. PubMed ID: 10626364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non platinum metal complexes as anti-cancer drugs.
    Ott I; Gust R
    Arch Pharm (Weinheim); 2007 Mar; 340(3):117-26. PubMed ID: 17315259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poor outcome of elderly patients with platinum-sensitive recurrent ovarian cancer: results from the SOCRATES retrospective study.
    Pignata S; Ferrandina G; Scarfone G; Scollo P; Odicino F; Cormio G; Katsaros D; Frigerio L; Mereu L; Ghezzi F; Manzione L; Lauria R; Breda E; Alletti DG; Ballardini M; Vernaglia A; Sorio R; Tumolo S; Musso P; Magni G; Pisano C; Morabito A
    Crit Rev Oncol Hematol; 2009 Sep; 71(3):233-41. PubMed ID: 19179095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EXAFS and IR structural study of platinum-based anticancer drugs' degradation by diethyl dithiocarbamate.
    Bouvet D; Michalowicz A; Crauste-Manciet S; Brossard D; Provost K
    Inorg Chem; 2006 Apr; 45(8):3393-8. PubMed ID: 16602799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 90.